Genetic breakthrough could see personalised prostate treatment

Almost nine out of ten men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs, according to a study that scientists hope will make possible a new era of personalised cancer treatment.